checkAd

     249  0 Kommentare Daré Bioscience’s DARE-LARC1 Platform Technology Achieves Proof-of-Concept Device that has Transformative Potential for Women’s Health as well as in Treating a Broad Range of Diseases - Seite 2

    To support development opportunities outside of the reproductive health category, including diabetes, obesity, and other conditions requiring precise and prolonged treatment, Daré plans to begin strategic discussions with potential industry partners.

    Daré is currently developing the platform technology internally with funding from a foundation grant in DARE-LARC1, a potential new class of long-acting, reversible contraceptive (LARC). If successful, DARE-LARC1 could provide women with unparalleled control over the management of their fertility to better meet specific individual family planning goals and objectives. As with other types of LARC products, investigational DARE-LARC1 is intended to provide effective contraception for an extended period without requiring day-to-day effort. Unlike current LARC products, DARE-LARC1’s innovative features include precision dosing, extended device duration and wireless control. DARE-LARC1 utilizes levonorgestrel, which is the active pharmaceutical ingredient in a number of FDA-approved birth control methods.

    Key features of the implant technology include:

    • Precision dosing: Unique design allows for precise dose timing and amount using individually addressable drug micro-reservoirs.
    • Extended duration and dosing interval control: The ability to house up to hundreds of individual doses means a single device can provide dosing over months to years.
    • No external charging or recharging required: A custom implant grade battery is designed to last for up to 20 years, depending on the application.
    • Upgradable platform: Device software can be updated without removal or replacement of the implant.
    • Two-way communication: Smart technology can respond wirelessly to queries from an external communication device to provide status updates, modify dosing, and deliver other application specific information.
    • Smartphone integration: Platform can be paired with custom mobile apps designed for each application to create a personalized experience for the user.

    About Daré Bioscience

    Daré Bioscience is a biopharmaceutical company committed to advancing innovative products for women’s health. The company’s mission is to identify, develop and bring to market a diverse portfolio of differentiated therapies that prioritize women's health and well-being, expand treatment options, and improve outcomes, primarily in the areas of contraception, vaginal health, reproductive health, menopause, sexual health and fertility.

    Seite 2 von 5


    Diskutieren Sie über die enthaltenen Werte


    globenewswire
    0 Follower
    Autor folgen

    Verfasst von globenewswire
    Daré Bioscience’s DARE-LARC1 Platform Technology Achieves Proof-of-Concept Device that has Transformative Potential for Women’s Health as well as in Treating a Broad Range of Diseases - Seite 2 Strategic Process Underway to Explore Partnering Opportunities for Additional Indications such as with GLP-1s for Obesity and Metabolic Disorders and Other Conditions Requiring Precise, Prolonged TreatmentSAN DIEGO, Jan. 04, 2024 (GLOBE NEWSWIRE) …

    Schreibe Deinen Kommentar

    Disclaimer